FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jose Luis Gonzalez-Larriba

Research Profile

Disorders

Chemicals & Drugs

Physiology

Mutation

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Sara Simonetti; Miguel Angel Molina; Cristina Queralt; Itziar de Aguirre; Clara Mayo; Jordi Bertran-Alamillo; José Javier Sanchez; Jose Luis Gonzalez-Larriba; Ulpiano Jimenez; Dolores Isla; Teresa Moran; Santiago Viteri; Carlos Camps; Rosario Garcia-Campelo; Bartomeu Massuti; Susana Benlloch; Miquel Taron; Santiago Ramon y Cajal; Rafael Rosell
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Screening for epidermal growth factor receptor mutations in lung cancer.
Joan Carles; E Esteban; Miguel Angel Climent; Albert Font; Jose Luis Gonzalez-Larriba; A Berrocal; I Garcia-Ribas; X Marfa; Xavier Fabregat; Joan Albanell; Joaquim Bellmunt
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jose Luis Gonzalez-Larriba (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Sara Simonetti; Miguel Angel Molina; Cristina Queralt; Itziar de Aguirre; Clara Mayo; Jordi Bertran-Alamillo; José Javier Sanchez; Jose Luis Gonzalez-Larriba; Ulpiano Jimenez; Dolores Isla; Teresa Moran; Santiago Viteri; Carlos Camps; Rosario Garcia-Campelo; Bartomeu Massuti; Susana Benlloch; Miquel Taron; Santiago Ramon y Cajal; Rafael Rosell
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
Journal of translational medicine 2010;8():135.
2009: Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Screening for epidermal growth factor receptor mutations in lung cancer.
The New England journal of medicine 2009;361(10):958-67.
2007: Joan Carles; E Esteban; Miguel Angel Climent; Albert Font; Jose Luis Gonzalez-Larriba; A Berrocal; I Garcia-Ribas; X Marfa; Xavier Fabregat; Joan Albanell; Joaquim Bellmunt
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1359-62.
2005: Hernán Cortes-Funes; C Gomez; Rafael Rosell; P Valero; Carlos Garcia-Giron; A Velasco; A Izquierdo; Pilar Diz; Carlos Camps; D Castellanos; Vicente Alberola; Felipe Cardenal; Jose Luis Gonzalez-Larriba; J M Vieitez; I Maeztu; Jose Javier Sanchez; Cristina Queralt; C Mayo; Pedro Méndez; T Moran; Miquel Taron
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1081-6.
2004: Angel Artal-Cortés; Jose Gomez-Codina; Jose Luis Gonzalez-Larriba; Isidoro Barneto; Alfredo Carrato; Dolores Isla; Carlos Camps; Carlos Garcia-Giron; Albert Font; Alfredo Meana; Maria Lomas; Catalina Vadell; Antonio Arrivi; Carmen Alonso; Inmaculada Maestu; Joaquin Campbell; Rafael Rosell
Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer.
Clinical lung cancer 2004;6(3):175-83.
2000: Enriqueta Felip; Rafael Rosell; Vicente Alberola; J Gómez-Codina; Jose Maestre; Julio Astudillo; Carlos Camps; Jose Luis Gonzalez-Larriba; I Moreno; A Paredes; Angel Artal; R García-Gómez; Pilar Garrido; Felipe Cardenal; Isidoro Barneto; José Javier Sánchez
Preoperative high-dose cisplatin versus moderate-dose cisplatin combined with ifosfamide and mitomycin in stage IIIA (N2) non small-cell lung cancer: results of a randomized multicenter trial.
Clinical lung cancer 2000;1(4):287-93.